BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10704690)

  • 1. Uneven frequencies of secondary chromosomal abnormalities in acute myeloid leukemias with t(8;21), t(15;17), and inv(16).
    Berger R; Coniat MB
    Cancer Genet Cytogenet; 2000 Mar; 117(2):159-62. PubMed ID: 10704690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16).
    McHale CM; Wiemels JL; Zhang L; Ma X; Buffler PA; Feusner J; Matthay K; Dahl G; Smith MT
    Blood; 2003 Jun; 101(11):4640-1. PubMed ID: 12756163
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities.
    Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L;
    Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368
    [No Abstract]   [Full Text] [Related]  

  • 4. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
    De Botton S; Chevret S; Sanz M; Dombret H; Thomas X; Guerci A; Fey M; Rayon C; Huguet F; Sotto JJ; Gardin C; Cony Makhoul P; Travade P; Solary E; Fegueux N; Bordessoule D; San Miguel J; Link H; Desablens B; Stamatoullas A; Deconinck E; Geiser K; Hess U; Maloisel F; Castaigne S; Preudhomme C; Chomienne C; Degos L; Fenaux P;
    Br J Haematol; 2000 Dec; 111(3):801-6. PubMed ID: 11122141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
    Langabeer SE; Grimwade D; Walker H; Rogers JR; Burnett AK; Goldstone AH; Linch DC
    Br J Haematol; 1998 May; 101(2):338-40. PubMed ID: 9609531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
    Andersen MK; Larson RA; Mauritzson N; Schnittger S; Jhanwar SC; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2002 Apr; 33(4):395-400. PubMed ID: 11921273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
    Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
    J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual color FISH on CBF primary acute myeloid leukemia.
    Sorour A; Nafea D
    Egypt J Immunol; 2008; 15(2):25-31. PubMed ID: 20306685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A greater incidence of complex translocations in myeloid leukemias than in lymphomas and lymphoid leukemias associated with IGH rearrangement.
    Fitzgerald PH; Morris CM
    Cancer Genet Cytogenet; 1996 Jan; 86(1):8-12. PubMed ID: 8616794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001.
    Forestier E; Heim S; Blennow E; Borgström G; Holmgren G; Heinonen K; Johannsson J; Kerndrup G; Andersen MK; Lundin C; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
    Br J Haematol; 2003 May; 121(4):566-77. PubMed ID: 12752097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRAS mutations are rare in acute myeloid leukaemias with t(8;21) or inv(16).
    Panagopoulos I; Aman P; Johansson B; Malm C; Lenhoff S; Billström R; Mitelman F
    Eur J Haematol; 1996; 56(1-2):68-71. PubMed ID: 8599996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group.
    Dastugue N; Payen C; Lafage-Pochitaloff M; Bernard P; Leroux D; Huguet-Rigal F; Stoppa AM; Marit G; Molina L; Michallet M
    Leukemia; 1995 Sep; 9(9):1491-8. PubMed ID: 7658718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 22 in acute myeloid leukemia: a marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16.
    Wong KF; Kwong YL
    Cancer Genet Cytogenet; 1999 Mar; 109(2):131-3. PubMed ID: 10087946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
    Rowe D; Cotterill SJ; Ross FM; Bunyan DJ; Vickers SJ; Bryon J; McMullan DJ; Griffiths MJ; Reilly JT; Vandenberghe EA; Wilson G; Watmore AE; Bown NP
    Br J Haematol; 2000 Dec; 111(4):1051-6. PubMed ID: 11167739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocytic sarcoma showing chromosomal changes other than the t(8;21).
    Heimann P; Vamos E; Ferster A; Sariban E
    Cancer Genet Cytogenet; 1994 May; 74(1):59-61. PubMed ID: 8194049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. t(1;2), inv(1) and trisomy 1q during the blastic phase of Philadelphia chromosome-positive chronic myeloid leukemia.
    Carbone P; Barbata G; Santoro A; Giglio MC; Mirto S; Granata G
    Acta Haematol; 1987; 77(4):198-202. PubMed ID: 3115029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
    Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
    J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary chromosomal abnormalities in acute leukemias.
    Johansson B; Mertens F; Mitelman F
    Leukemia; 1994 Jun; 8(6):953-62. PubMed ID: 8207990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic studies in de novo acute nonlymphocytic leukemia.
    Wei CH; Luh YM; Liu JH; Fan S; Hsieh RK; Chiou TJ; Tzeng CH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Apr; 55(4):296-301. PubMed ID: 7796356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.